World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions.

WHO CVD Risk Chart Working Group. · 2019

Read World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. by WHO CVD Risk Chart Working Group. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7025029.txt.

Introduction

The WHO CVD Risk Chart Working Group presents revised heart disease risk charts in The Lancet Global Health. The charts estimate a person's 10-year risk of heart attack or stroke. Older charts fitted wealthy countries poorly matched low-income and middle-income settings, so the World Health Organization convened this effort to rebuild them for 21 global regions.

The models use age, smoking, systolic blood pressure, diabetes history, and total cholesterol. They were derived from 376,177 people in 85 cohorts, all aged 40 to 80 with no known cardiovascular disease at entry. The team then recalibrated each model with regional incidence and risk factor data, and tested it on separate studies. The charts let clinics judge risk where laboratory testing may be limited.

Catalog record

CREATORWHO CVD Risk Chart Working Group.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE74 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7025029

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions Published in: The Lancet. Global Health DOI: 10.1016/S2214-109X(19)30318-3 ABSTRACT Summary Background To help adapt cardiovascular disease risk prediction approaches to low-income and middle-income countries, WHO has convened an effort to develop, evaluate, and illustrate revised risk models. Here, we report the derivation, validation, and illustration of the revised WHO cardiovascular disease risk prediction charts that have been adapted to the circumstances of 21 global regions. Methods In this model revision initiative, we derived 10-year risk prediction models for fatal and non-fatal cardiovascular disease (ie, myocardial infarction and stroke) using individual participant data from the Emerging Risk Factors Collaboration. Models included information on age, smoking status, systolic blood pressure, history of diabetes, and total cholesterol. For derivation, we included participants aged 40–80 years without a known baseline history of cardiovascular disease, who were followed up until the first myocardial infarction, fatal coronary heart disease, or stroke event. We recalibrated models using age-specific and sex-specific incidences and risk factor values available from 21 global regions. For external validation, we analysed individual participant data from studies distinct from those used in model derivation. We illustrated models by analysing data on a further 123 743 individuals from surveys in 79 countries collected with the WHO STEPwise Approach to Surveillance. Findings Our risk model derivation involved 376 177 individuals from 85 cohorts, and 19 333 incident cardiovascular events recorded during 10 years of follow-up. The derived risk prediction models discriminated well in external validation cohorts (19 cohorts, 1 096 061 individuals, 25 950 cardiovascular disease events), with Harrell's C indices ranging from 0·685 (95% CI 0·629–0·741) to 0·833 (0·783–0·882). For a given risk factor profile, we found substantial variation across global regions in the estimated 10-year predicted risk. For example, estimated cardiovascular disease risk for a 60-year-old male smoker without diabetes and with systolic blood pressure of 140 mm Hg and total cholesterol of 5 mmol/L ranged from 11% in Andean Latin America to 30% in central Asia. When applied to data from 79 countries (mostly low-income and middle-income countries), the proportion of individuals aged 40–64 years estimated to be at greater than 20% risk ranged from less than 1% in Uganda to more than 16% in Egypt. Interpretation We have derived, calibrated, and validated new WHO risk prediction models to estimate cardiovascular disease risk in 21 Global Burden of Disease regions. The widespread use of these models could enhance the accuracy, practicability, and sustainability of efforts to reduce the burden of cardiovascular disease worldwide. Funding World Health Organization, British Heart Foundation (BHF), BHF Cambridge Centre for Research Excellence, UK Medical Research Council, and National Institute for Health Research. INTRODUCTION By the year 2030, the UN Sustainable Development Goals1 aim to reduce premature mortality from non-communicable diseases by a third. Cardiovascular diseases (which include coronary heart disease and stroke) are the most common non-communicable diseases globally, responsible for an estimated 17·8 million deaths in 2017, of which more than three quarters were in low-income and middle-income countries.2 To help reduce the global burden of cardiovascular disease, WHO member states have committed to provide counselling and drug treatments for at least 50% of eligible people (defined as aged 40 years or older and at high risk of cardiovascular disease) by 2025.3 To support such expansion of cardiovascular disease prevention and control efforts, WHO has developed tools and guidance, including risk prediction charts.4, 5 Risk prediction models can be a component of cardiovascular disease prevention and control efforts, because they can help to identify people at high risk of cardiovascular disease who should benefit the most from preventive interventions.6, 7 Many such risk prediction models have been developed,8, 9, 10, 11, 12, 13 usually estimating individual risk over a 10-year period by use of measured levels of conventional risk factors for cardiovascular disease.14 However, available models have limitations for use in low-income and middle-income countries. Most models were derived and validated with use of a narrow set of studies, might be directly applicable only to specific populations (mainly in high-income countries), and might not predict the correct risk in the target population being screened (ie, poor calibration).8, 13, 15, 16, 17, 18 Research in contextEvidence before this studyTo update the 2007 WHO and International Society of Hypertension's cardiovascular disease risk prediction approaches, WHO has convened an informal risk-chart working group. To inform this work, we searched PubMed, Scientific Citation Index Expanded, and Embase to identify existing risk prediction models for cardiovascular disease in the context of primary prevention published in any language up to May 15, 2019, using the relevant terms: “cardiovascular disease”, “risk score”, “risk equation”, “risk algorithm”, and “risk prediction”. We found many studies and reviews describing risk prediction models to estimate cardiovascular disease risk in a primary prevention context. However, none had combined the following key features necessary to develop reliable risk models relevant to low-income and middle-income countries: use of powerful and diverse global data, simple and generalisable methods to account for differences in populations (ie, to allow recalibration), and inclusion of information that is readily available in many low-income and middle-income countries.Added value of this studyThe newly developed risk models involve several features that should confer advantages compared with existing tools. First, they are underpinned by powerful, extensive, and complementary datasets of global relevance. Second, we used comprehensive contemporary estimates of cardiovascular disease incidence and risk factor values to adapt (ie, recalibrate) the risk models to many different populations using a simpler and more generalisable approach than that of previous studies. Third, these models provide estimates for the combined outcome of fatal and non-fatal events. Fourth, they include pragmatic models that do not assume availability of laboratory measurements (eg, serum lipid concentrations) that could be used as part of stepwise approaches to help target laboratory testing in people most likely to benefit from the extra information.Implications of all the available evidenceWe have derived, validated, and illustrated new WHO models for cardiovascular disease risk prediction adapted for the needs of low-income and middle-income countries, to support tools and guidance for cardiovascular disease prevention and control. The widespread use of these models could enhance the accuracy, practicability, and sustainability of efforts to reduce the burden of cardiovascular disease worldwide. Here, we provide derivation, validation, and illustration of updated WHO models for cardiovascular disease risk prediction. To enhance targeting of efforts to reduce the burden of cardiovascular disease, we have statistically adapted (ie, recalibrated)14, 19 models to the contemporary circumstances of many different global regions using routinely available information. The aim of recalibration was to ensure that risk prediction models estimate risk for individuals in each region more accurately. To help make this approach more sustainable, we developed and describe here a method that can be used to regularly update risk prediction models using information about epidemiological trends in cardiovascular disease within different global regions. The WHO CVD Risk Chart Working Group, a cross-sectoral collaboration of academics, policy makers, and end users of risk scores, was convened to facilitate this development of revised models for prediction of cardiovascular disease risk more tailored to the needs of low-income and middle-income countries. METHODS Study design In our model revision initiative, several

Read the complete text